Pricing Log in Create free account
Saturday 7 November 2026 Export AMS’s income statement to Excel — free account

American Shared Hospital Services

AMS Healthcare Medical Care Facilities

American Shared Hospital Services' revenue for fiscal 2025 (year ended December 2025) was $28.1 million, down 0.91% from fiscal 2024.

Revenue
+19.2%
EPS
−75.0%
Free cash flow
+195.8%
Total debt
−32.7%

Quarter to June 2026, against a year earlier

1.17 0.00 0.00%
Market cap
$7.8M
P/E
0.0×
Fwd P/E
1.8×
Dividend yield
—
F-score
3/9
Altman Z
0.67
Beneish M
−2.06
Dividend safety
10/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Bought, $m 1.34
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — 1 — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 35.83%

Capital & Financial Ratios $m

Size
Market Cap 7.78
Revenue ttm 30.41
Net income ttm (3.30)
Free cash flow ttm 3.54
Net debt Q 9.46
Valuation
P/E 0.00
Forward P/E 1.80
Price / sales 0.26
Forward P/S Powerpack
Price / FCF 2.27
Price / book 0.31
Financial health
Current ratio Q 0.77 (below 1: weak)
Debt / equity Q 0.63
Interest coverage Q (2.02)
Growth
Revenue growth Q +19.22% (above 0%: growing)
Operating income growth Q −67.28% (below 0%: shrinking)
EPS, this year +39.13% (at or above 15%: strong)
EPS, next year A −43.40% (below 0%: weak)
Revenue, next year A +55.16% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.9×, against a ten-year median of 1.2×; over the ten years it ranged from 0.6× in 2020 to 2.4× in 2017.
P/S against its own 10 years 0.07%
10-year low 10-year high
P/B against its own 10 years 1.47%
10-year low 10-year high
EV/Sales against its own 10 years 10.15%
10-year low 10-year high
EV/FCF against its own 10 years 95.72%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 14 11 4 7
Receivables 5 12 12 9
Inventory — — — —
Other — — — —
20 26 18 17
2023 2024 2025 Q'26
Payables 0 2 1 1
ST’ Debt 5 3 17 16
Other 3 4 4 3
11 10 23 22

Compound Annual Growth %

10y 5y 3y
Sales 5.43% 9.50% 12.46%
Cash Flow (9.65%) (20.48%) (24.63%)
Earnings 0.00% 0.00% 0.00%
Book Value 0.96% 3.21% 2.62%

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate −0.02 Actual −0.07

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 0.00 0.00 Met by 0.00
Q4 FY25 0.02 −0.09 Miss by 0.11
Q1 FY26 −0.01 −0.09 Miss by 0.08
Q2 FY26 −0.02 −0.07 Miss by 0.05
Q3 FY26 0.01 — Reports 12 November 2026

EPS $

Mar Jun Sep Dec Year
’26 (0.09) (0.07) — — —
’25 (0.10) (0.04) 0.00 (0.09) (0.23)
’24 0.02 0.55 (0.03) (0.20) 0.33
’23 0.03 (0.02) 0.02 0.06 0.10
’22 0.04 0.08 0.05 0.04 0.21
’21 0.00 (0.01) 0.01 0.04 0.03
’20 (0.02) (0.08) (0.03) (1.01) (1.14)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 7 8 — — —
’25 6 7 7 8 28
’24 5 7 7 9 28
’23 5 6 5 6 21
’22 5 5 5 5 20
’21 4 4 4 5 18
’20 5 4 5 5 18
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 2 2 — — —
’25 3 0 2 (1) 3
’24 (2) 1 0 0 0
’23 2 3 4 (3) 6
’22 0 4 2 2 7
’21 3 1 (1) 3 6
’20 3 3 1 2 10
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 2 2 — — —
’25 (2) (2) (2) 1 (5)
’24 (3) 0 0 (4) (7)
’23 2 1 0 (3) (1)
’22 0 4 1 2 7
’21 2 2 (1) 2 5
’20 3 3 1 2 9
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 19 20 20 21 18 18 20 21 28 28 30 +4.6% 44 — — +55.2%
Gross margin, % 47.03 44.30 37.97 33.58 25.04 38.16 42.45 43.82 32.41 18.03 17.14 (29.0) pt
EBT 3 2 2 2 (9) 1 3 1 1 (3) (3) n/m
EBT margin, % 17.07 9.39 10.56 7.56 (53.00) 5.37 12.75 3.26 4.36 (11.47) (10.58) (28.5) pt
Net income 2 3 2 1 (8) 1 2 0 2 (3) (3) n/m
Per share, $
Per share, $ Revenue 3.36 3.40 3.38 3.48 2.89 2.92 3.14 3.35 4.36 4.24 4.43 +2.6%
Earnings 0.17 0.33 0.18 0.11 (1.14) 0.03 0.21 0.10 0.34 (0.23) (0.25) n/m
Cash flow 1.50 1.36 1.38 1.36 1.58 1.04 1.15 0.90 0.03 0.47 0.78 (12.2%)
Capex (0.19) (0.11) (0.27) (0.17) (0.05) (0.28) (0.06) (0.99) (1.18) (1.15) (0.26) +22.4%
Free cash flow 1.32 1.25 1.11 1.19 1.53 0.76 1.09 (0.09) (1.15) (0.69) 0.51 n/m
Book value 4.88 5.19 5.32 5.37 3.83 4.01 4.07 4.13 4.62 4.19 3.76 (1.7%)
Shares, m 6 6 6 6 6 6 6 6 6 7 7 +1.9%
Valuation, ×
Valuation, × P/E 20.00 7.73 13.22 20.33 0.00 59.25 14.00 26.67 9.11 0.00 0.00 17.0
P/S 1.01 0.75 0.70 0.70 0.77 0.81 0.94 0.72 0.73 0.50 0.26 0.8
P/B 0.70 0.49 0.45 0.45 0.58 0.59 0.72 0.58 0.69 0.50 0.31 0.6
EV/Sales 2.03 1.56 0.89 0.82 0.95 1.24 0.99 0.80 1.05 1.29 0.86 1.2
EV/FCF 5.18 4.24 2.71 2.40 1.80 4.75 2.85 (30.77) (3.96) (7.97) 7.39 (1.9)
Cash, $m
Cash, $m Operating cash flow 8 8 8 8 10 6 7 6 0 3 5 (10.5%)
Capex (1) (1) (2) (1) 0 (2) 0 (6) (8) (8) (2) +24.8%
Free cash flow 7 7 6 7 9 5 7 (1) (7) (5) 4 n/m
Balance, $m
Balance, $m Working capital (1) 0 0 3 (2) 9 14 10 16 (6) (5) +24.2%
Net debt 19 16 4 3 3 8 1 2 9 14 9 (3.7%)
Shareholders’ equity 27 30 31 32 24 24 26 26 30 28 26 +0.2%
Returns, %
Returns, % ROA 1.62 3.24 1.77 1.18 (14.49) 0.44 2.97 1.32 4.03 (2.69) (3.06) (4.3) pt
ROIC 4.44 3.30 3.35 2.81 (21.99) 2.66 5.70 0.60 (4.50) (5.43) (6.34) (9.9) pt
ROE 3.55 6.74 3.36 2.10 (25.45) 0.81 5.33 2.35 7.76 (5.38) (6.49) (8.9) pt
People
People Employees 9 9 9 9 10 9 11 13 44 46 — +19.9%
Revenue/emp, $m 2.08 2.17 2.19 2.29 1.78 1.96 1.80 1.64 0.64 0.61 — (12.7%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

American Shared Hospital Services vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
BMGL Basel Medical Group Ltd $70.5M — — — — — — — Compare
CCEL Cryo-Cell International Inc. $39.9M — (loss-making) 65.1× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
BTMD biote Corp. $37.4M 6.6× — (loss-making) −9.48% (below 0%: shrinking) n/m −174.16% (below 0%: shrinking) 65.38% (7.93%) Compare
PIII P3 Health Partners Inc. $28.1M — (loss-making) — +8.60% (above 0%: growing) n/m −272.24% (below 0%: shrinking) 22.26% 10.67% Compare
DCGO DocGo Inc. $24.1M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
CCM Concord Medical Services Holdings Limited $10.0M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
AMS American Shared Hospital Services $7.8M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%)
RHEP Adcare Health Systems Inc $5.2M 0.6× — (loss-making) +143.03% (above 0%: growing) n/m +224.45% (above 0%: growing) 31.50% (0.88%) Compare
SYRA Syra Health Corp. $1.1M 14.7× — +51.50% (above 0%: growing) n/m +235.76% (above 0%: growing) 46.34% 11.73% Compare
Median of peers $26.1M 6.6× — +8.60% — −132.28% 31.50% 0.00%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 30 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 526.40k 523.25k 71.00
2024 603.29k 666.59k 132.00
2023 626.60k 588.50k 81.00
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Read the proxy statement

American Shared Hospital Services (AMS) Latest News

20 Oct

Impact 3 · · Simply Wall St.

1 Oct

Impact 3 · · Simply Wall St.
Impact 3 · · Simply Wall St.

21 Aug

Impact 4 ·

20 Aug

Impact 3 · · The Motley Fool transcript

13 Aug

Impact 5 ·
Impact 4 ·
Impact 3 · transcript
Impact 3 · · Moby transcript
Impact 3 ·

18 May

Impact 3 · · Zacks Small Cap Research

14 May

Impact 4 · · GuruFocus.com
Impact 3 · · Moby
Impact 3 ·

8 Apr

Impact 3 · · Zacks Small Cap Research

1 Apr

Impact 4 · · Moby

31 Mar

Impact 4 · · GuruFocus.com
Impact 3 · · GlobeNewswire

25 Feb

Impact 4 · · Zacks Small Cap Research

20 Nov

Impact 3 · · Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St.

19 Nov

Impact 4 · · Simply Wall St.

17 Nov

Impact 4 · · Zacks Small Cap Research

13 Nov

Impact 4 · · GuruFocus.com transcript
Impact 4 · · GlobeNewswire

6 Nov

Impact 3 · · GlobeNewswire

10 Oct

Impact 3 · · Simply Wall St.

9 Sep

Impact 3 · · Simply Wall St.

19 Aug

Impact 4 · · Zacks Small Cap Research

14 Aug

Impact 4 · · GuruFocus.com

6 Aug

Impact 3 · · GlobeNewswire
stockrow.com/AMS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com